Affordable Access

deepdyve-link
Publisher Website

Improving safety of autologous haematopoietic stem cell transplantation in patients with Crohn's disease.

Authors
  • Jauregui-Amezaga, Aranzazu1
  • Rovira, Montserrat2
  • Marín, Pedro3
  • Salas, Azucena1
  • Pinó-Donnay, Susana1
  • Feu, Faust1
  • Elizalde, J Ignasi1
  • Fernández-Avilés, Francesc2
  • Martínez, Carmen2
  • Gutiérrez, Gonzalo2
  • Rosiñol, Laura2
  • Carreras, Enric2
  • Urbano, Alvaro2
  • Lozano, Miguel3
  • Cid, Joan3
  • Suárez-Lledó, María2
  • Mensa, Josep4
  • Rimola, Jordi5
  • Rodríguez, Sonia5
  • Masamunt, Mari Carme1
  • And 7 more
  • 1 Gastroenterology Department, Hospital Clínic de Barcelona, IDIBAPS, CIBERehd, Barcelona, Spain. , (Spain)
  • 2 Hematology Department, Hospital Clínic de Barcelona, Barcelona, Spain. , (Spain)
  • 3 Hemotherapy and Hemostasis Department, Hospital Clínic de Barcelona, Barcelona, Spain. , (Spain)
  • 4 Infectious Diseases Department, Hospital Clinic de Barcelona, Barcelona, Spain. , (Spain)
  • 5 Radiology Department, Hospital Clínic de Barcelona, Barcelona, Spain. , (Spain)
Type
Published Article
Journal
Gut
Publisher
BMJ
Publication Date
Sep 01, 2016
Volume
65
Issue
9
Pages
1456–1462
Identifiers
DOI: 10.1136/gutjnl-2015-309836
PMID: 26585938
Source
Medline
Keywords
License
Unknown

Abstract

Autologous HSCT for patients with refractory CD is feasible, but extraordinary supportive measures need to be implemented. We suggest that this procedure should only be performed in highly experienced centres.

Report this publication

Statistics

Seen <100 times